Athena Athena

X

Find Radio Compass News for Dexamethasone

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
744
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • SUSPENSION/DROPS;OPHTHALMIC - 0.1%
  • SUSPENSION/DROPS;OTIC - 0.3%;0.1%
  • OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM
  • SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%
  • OINTMENT;OPHTHALMIC - 0.1%;0.3%
  • SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%
  • TABLET;ORAL - 1.5MG
  • TABLET;ORAL - 4MG
  • TABLET;ORAL - 0.75MG
  • TABLET;ORAL - 2MG
  • ELIXIR;ORAL - 0.5MG/5ML
  • TABLET;ORAL - 6MG

https://www.prnewswire.com/news-releases/affamed-therapeutics-announces-new-drug-application-acceptance-by-singapore-health-sciences-authority-hsa-for-dextenza-for-treatment-of-ocular-inflammation-and-pain-following-ophthalmic-surgery-and-ocular-itching-associated-wi-302064649.html

PR NEWSWIRE
19 Feb 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216283

FDA
07 Feb 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216282

FDA
07 Feb 2024

https://www.fiercepharma.com/pharma/gsk-details-blenrep-combo-data-could-bring-multiple-myeloma-adc-back-life

FIERCE PHARMA
06 Feb 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-says-blood-cancer-drug-meets-primary-goal-late-stage-trial-2023-11-27/

REUTERS
28 Nov 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217695

FDA
23 Aug 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215768

FDA
09 Jun 2023

https://www.asiaone.com/business/affamed-therapeutics-announces-completion-patient-enrollment-real-world-study-china

ASIAONE
31 May 2023

https://www.prnewswire.com/news-releases/affamed-therapeutics-announces-completion-of-patient-enrollment-in-the-real-world-study-in-china-evaluating-the-safety-and-efficacy-of-dextenza-in-cataract-surgery-patients-301838072.html

PR NEWSWIRE
31 May 2023

https://www.prnewswire.com/news-releases/antengene-announces-xpovio-plus-bortezomib-and-dexamethasone-included-for-reimbursement-by-the-pbs-in-australia-for-the-treatment-of-relapsed-andor-refractory-multiple-myeloma-301839510.html

PR NEWSWIRE
31 May 2023

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217696

FDA
09 May 2023

https://www.prnewswire.com/news-releases/affamed-therapeutics-announces-approval-to-initiate-a-phase-3-registrational-clinical-trial-in-mainland-china-for-dextenza-for-the-treatment-of-ocular-inflammation-and-pain-following-ophthalmic-surgery-301797505.html

PR NEWSWIRE
17 Apr 2023

https://www.prnewswire.com/news-releases/karyopharm-and-menarini-group-receive-full-marketing-authorization-from-the-uk-medicines--healthcare-products-regulatory-agency-for-nexpovio-selinexor-in-combination-with-bortezomib-and-dexamethasone-for-the-treatment-of-adult-301751848.html

PR NEWSWIRE
21 Feb 2023

https://www.businesswire.com/news/home/20230123005117/en

BUSINESSWIRE
23 Jan 2023

https://www.fiercepharma.com/pharma/novartis-isnt-done-shaking-things-sells-five-eyecare-drugs-harrow-130-million

Zoey Becker FIERCEPHARMA
15 Dec 2022

https://www.prnewswire.com/news-releases/janssen-presents-efficacy-and-subgroup-analyses-from-maia-study-showing-long-term-results-of-darzalex-daratumumab-based-regimen-in-newly-diagnosed-transplant-ineligible-multiple-myeloma-301700443.html

PRNEWSWIRE
12 Dec 2022

https://www.businesswire.com/news/home/20221207005812/en

BUSINESSWIRE
07 Dec 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210470

FDA
30 Aug 2022

https://www.clinicaltrialsarena.com/news/janssen-trial-multiple-myeloma/

CLINICALTRIALSARENA
29 Aug 2022

https://endpts.com/those-big-billion-dollar-phiii-studies-martin-landray-says-they-can-be-done-for-a-tiny-fraction-of-the-cost/

ENDPTS
18 Aug 2022

https://www.businesswire.com/news/home/20220816005393/en

BUSINESSWIRE
16 Aug 2022

https://www.pharmatimes.com/news/santen_launches_ducressa_for_post-cataract_surgery_1453357

John Pinching PHARMATIMES
15 Aug 2022

https://news.cision.com/abbvie/r/nice-recommendation-expands-patient-eligibility-for-abbvie-s-ozurdex---dexamethasone-0-7mg-intravitr,c3613044

NEWSCISION
11 Aug 2022

https://firstwordpharma.com/story/5635171

FIRSTWORDPHARMA
11 Aug 2022

https://www.europeanpharmaceuticalreview.com/news/173574/trio-of-therapies-reduces-risk-of-death-in-patients-with-severe-covid-19/

EUROPEAN PHARMACEUTICAL REVIEW
11 Aug 2022

https://www.pharmatimes.com/news/smc_approve_johnson_and_johnsons_systemic_light_chain_amyloidosis_therapy_1453205

John Pinching PHARMA TIMES
10 Aug 2022

http://www.pharmafile.com/news/721160/smc-accepts-first-licensed-treatment-newly-diagnosed-al-amyloidosis

PHARMAFILE
09 Aug 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215604

FDA
08 Aug 2022

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/latin-foods-market-issues-voluntary-nationwide-recall-artri-king-reforzado-con-ortiga-y-omega-3-due

FDA
15 Jun 2022

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-15-2022-1655268880.pdf

FDA
14 Jun 2022

https://www.clinicaltrialsarena.com/news/sanofi-multiple-myeloma-trial/

CLINICALTRIALSARENA
16 May 2022

https://www.fiercepharma.com/pharma/seeking-shake-eye-inflammation-market-optifye-and-delsitech-partner-controlled-release-drops

N.P. Taylor FIERCEPHARMA
30 Mar 2022

https://padagis.com/padagis-annouces-the-fda-approval-and-launch-of-an-ab-rated-generic-version-of-tobradex-ophthalmic-suspension/

PRESS RELEASE
21 Mar 2022

https://www.prnewswire.com/news-releases/antengene-announces-xpovio-approved-by-the-tga-in-australia-for-the-treatment-of-relapsed-andor-refractory-multiple-myeloma-and-triple-class-refractory-multiple-myeloma-301498919.html

PRNEWSWIRE
09 Mar 2022

https://www.fiercepharma.com/pharma/bristol-myers-squibbs-revlimid-finally-faces-competition-us-tevas-generic-launch

K. Dunleavy FIERCEPHARMA
08 Mar 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212715

FDA
11 Feb 2022

https://www.globenewswire.com/news-release/2022/02/07/2379644/0/en/Active-Biotech-announces-first-patient-dosed-in-the-combination-part-of-the-phase-Ib-IIa-study-of-tasquinimod-in-multiple-myeloma.html

GLOBENEWSWIRE
07 Feb 2022

https://www.businesswire.com/news/home/20220118005422/en

BUSINESSWIRE
18 Jan 2022

https://www.prnewswire.com/news-releases/oncopeptides-phase-3-ocean-study-published-in-the-lancet-haematology-301460221.html

PRNEWSWIRE
12 Jan 2022

http://www.pharmafile.com/news/600992/nice-recommends-combination-treatment-patients-multiple-myeloma

PHARMAFILE
24 Dec 2021

https://www.businesswire.com/news/home/20211220005121/en

BUSINESSWIRE
20 Dec 2021

https://www.fiercepharma.com/pharma/sanofi-johnson-johnson-collision-course-sarclisa-darzalex-4-drug-multiple-myeloma

Angus Liu FIERCEPHARMA
11 Dec 2021

https://www.businesswire.com/news/home/20211211005041/en

BUSINESSWIRE
11 Dec 2021

https://www.prnewswire.com/news-releases/halozyme-announces-janssen-receives-us-fda-approval-of-darzalex-faspro-daratumumab-and-hyaluronidase-fihj-in-combination-with-carfilzomib-and-dexamethasone-for-patients-with-multiple-myeloma-after-first-or-subsequent-relapse-301435510.html

PRNEWSWIRE
01 Dec 2021

https://www.prnewswire.com/news-releases/ntc-und-aspen-geben-positives-sahpra-ergebnis-fur-die-fest-dosierte-kombination-aus-levofloxacin-und-dexamethason-augentropfen-in-mehreren-dosen-bekannt-809733682.html

PRNEWSWIRE
24 Nov 2021

https://www.reuters.com/business/healthcare-pharmaceuticals/jj-sees-potential-14-new-multibillion-dollar-drugs-by-2025-2021-11-18/

M. Erman REUTERS
19 Nov 2021

https://www.businesswire.com/news/home/20211027005168/en/Amneal-Launches-Generic-Dexamethasone-Following-ANDA-Approval-by-FDA

BUSINESSWIRE
27 Oct 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215106

FDA
19 Oct 2021

https://seekingalpha.com/news/3752261-health-canada-approves-sanofis-sarclisa-combination-for-multiple-myeloma

Mamta Mayani SEEKINGALPHA
13 Oct 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY